Ana Paula Souto Melo

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016

Valéria Maria de Azeredo Passos, Déborah Carvalho Malta, Elizabeth Barboza França et al. · The Lancet · 2018 · 461 citations · Full text

Public Health, Health Policy, Health Sciences +17

Cause-specific mortality for 249 causes in Brazil and states during 1990–2015: a systematic analysis for the global burden of disease study 2015

Elisabeth Barboza França, Valéria Maria de Azeredo Passos, Déborah Carvalho Malta et al. · Population Health Metrics · 2017 · 155 citations · Full text

Public Health, Health Sciences, Population Health Sciences +17

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

All-cause and cause-specific mortality among people with severe mental illness in Brazil's public health system, 2000–15: a retrospective study

Ana Paula Souto Melo, Ilse N Dippenaar, Sarah Charlotte Johnson et al. · The Lancet Psychiatry · 2022 · 62 citations · Full text

Medicine, Health Sciences, Psychiatry +10